AlzChem Group AG

AlzChem Group AG operates globally, engaging in the development, production, and distribution of a wide array of chemical products through its subsidiaries. The company's reach extends across Germany, the European Union, the rest of Europe, Asia, the NAFTA region, and other international markets. Its business is organized into three primary divisions: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The diverse product portfolio includes prominent dietary supplements such as Creapure® and Alipure®, along with the creatine-based LIVADUR®. For animal nutrition, AlzChem supplies Creamino®, a guanidinoacetic acid preparation. The pharmaceutical industry benefits from its Bioselect® brand. Industrial applications feature DYHARD® curing agents, acting as accelerators in adhesives, powder coatings, printed circuit boards, and composites, while SILZOT® silicon nitride is vital for ceramics, electronics, and solar technology. The company also manufactures a variety of fine and foundational chemicals, encompassing products derived from calcium carbide, calcium cyanamide (marketed as PERLKA®), hydrogen cyanamide, dicyandiamide, guanidine, guanamines, nitroguanidine, and various aromatic and aliphatic nitriles. Its agricultural offerings include ALZOGUR® germicide for pig pens, Dormex® and Sitofex® plant growth regulators, and BREAK-THRU® plant protection additives. Furthermore, AlzChem provides crucial products for hot metal desulfurization and secondary metallurgy, in addition to technical gases. Beyond its core chemical activities, the group also oversees chemical park operations, offers administrative assistance, and delivers a range of infrastructure services. Established in 1908, AlzChem Group AG maintains its headquarters in Trostberg, Germany.

AlzChem Group AG trades as ACT.DE on XETRA. The company is classified in Basic Materials / Chemicals - Specialty and reports in EUR.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

AlzChem Group AG can be compared against peers such as Indorama Ventures Public Company Limited, Lanxess AG, Masterflex SE, Nabaltec AG, Wesdome Gold Mines Ltd., K+S AG.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of €1.76B, beta of 0.57, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ACT.DE currently shows total debt of N/A and beta of 0.57. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.alzchem.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.